๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shenzhen
Clinical trial register · China

Clinical Trials in Shenzhen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shenzhen 11
Narrow the registerReset
Recruitment status
Phase
Site location
Shenzhen11
All 1 locations
Target enrolment
to

Trials with a site in Shenzhen

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
NCT07563179Acute Myeloid Leukemia, Relapse/Recurrence
Shenzhen University General Hospital
Phase 2
10
Shenzhen
2026-04-21
Recruiting
Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma
NCT07508605Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital
Phase 1/2
20
Shenzhen
2025-01-01
Recruiting
Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
NCT07584889B Cell Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Shenzhen University General Hospital
Phase 1/2
10
Shenzhen
2024-04-20
Not yet open
Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
NCT06234072Pancreatic Cancer
Shenzhen University General Hospital
Phase 2
120
Shenzhen
2024-02
Recruiting
Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors
NCT07399769Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital
Phase 1/2
20
Shenzhen
2024-01-01
Recruiting
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
NCT07097207Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital
Phase 1/2
20
Shenzhen
2023-10-01
Recruiting
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
NCT06644443Multiple Myeloma in Relapse
Shenzhen University General Hospital
Phase 1/2
10
Shenzhen
2023-07-15
Recruiting
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NCT05620693Advanced Soft-tissue Sarcoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-11-11
Recruiting
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
NCT05620706Advanced Hepatocellular Carcinoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-11-01
Recruiting
CD7 CAR-T Cells in T-cell Lymphoma/Leukemia
NCT05620680T Lymphoblastic Leukemia/Lymphoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-10-01
Recruiting
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
NCT05620732Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-10-01
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/shenzhen

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Shenzhen that also match the filters currently applied.

How many clinical trials are recruiting in Shenzhen?

10 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenzhen), 11 studies
PhaseStudiesRecruitingShare
Phase 1/25545.5%
Not applicable4436.4%
Phase 22118.2%

Most active sponsors

Lead sponsors with the most studies (Shenzhen)
Lead sponsorStudiesRecruiting
Shenzhen University General Hospital1110
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.